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Summary  Sickle  cell  disease  (SCD)  is  a  hereditary  blood  disorder  characterized
by  abnormal  red  blood  cell  shape  (sickling).  The  incidence  of  the  disease  in  the
Kingdom  of  Bahrain  is  approximately  2.1%.  Patients  with  SCD  are  prone  to  multiple
health  complications,  some  of  which  are  fatal.  A  retrospective  study  was  conducted
at  the  Salmaniya  Medical  Complex  in  the  Kingdom  of  Bahrain  from  June,  2012  to
December,  2012  to  assess  the  incidence  of  fever  among  the  SCD  in-patients  at  that
institution.  The  study  also  assessed  the  antibiotics  administered,  type  of  organisms
isolated  and  patient  outcome.  The  results  showed  that  a  total  of  59  patients  devel-
oped  fever  and  33  of  those  with  fever  had  a  positive  culture  result  (55.93%).  The
most  common  isolate  was  gram-positive  bacteria,  most  commonly  Staphylococcus
epidermidis  (42.86%),  and  ceftriaxone  was  the  most  commonly  prescribed  antimi-
crobial.  In  conclusion,  there  was  a  low  rate  of  hospital  acquired  infection  and  special
attention  needs  to  be  paid  to  the  infection  control  measures  for  SCD  patients.  For
most  of  the  SCD  fever  cases,  there  was  no  clear  cause  of  the  fever  even  after  exten-
sive  diagnostic  evaluations;  thus,  those  fevers  may  have  been  of  a  non-infectious
etiology  in  this  population.  Fortunately,  none  of  the  patients  had  any  of  the  com-tionsmon  preventable  infec
vaccination  program  in  plac
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Introduction
Sickle  cell  disease  (SCD)  is a  hereditary  blood  dis-
order  characterized  by  abnormal  red  blood  cell
shape  (sickling).  This  abnormal  shape  decreases
the cell’s  ﬂexibility  and  results  in  multiple  com-
plications. This  abnormality  is  due  to  a  mutation
in the  hemoglobin  gene  that  results  in an  amino
acid substitution  of  valine  for  glutamine  in  the  
chain. The  mutation  can  occur  in  a  heterozygous
(SCD trait)  or  homozygous  form.  The  disease  has
multiple  acute  and  chronic  complications,  including
hemolysis  crises,  severe  pain,  renal  complications,
thromboembolic  phenomenon  and  overwhelming
infections,  and  some  complications  of  SCD  generate
high mortality.
Infections  in  SCD  patients  are  relatively  com-
mon and  are  spread  easily  for  various  reasons.
SCD patients  are  prone  to  invasive  infections  with
encapsulated  bacteria.  SCD  patients  should  be
assumed  to  be  functionally  asplenic  even  if  their
spleen  is  not  surgically  removed.  Bacteremia  car-
ries signiﬁcant  risk  of  morbidity  and  mortality  in  this
group of  patients  despite  the  protocols  for  routine
vaccination.
In a  study  conducted  in  a  hospital  population  in
Bahrain,  which  included  5503  neonates  and  50,695
non-neonates,  the  prevalence  of  SCD  was  reported
as 2.1  percent.  The  prevalence  of  the  HbS  trait
was reported  as  18.1  percent  in  neonates,  and
only 10.44  percent  of  the  SCD  patients  were  non-
neonatal  patients  [1].  Thus,  SCD  patients  occupy
a signiﬁcant  percentage  of  the  Bahraini  population
and, as  a  result,  impose  a  considerable  burden  on
Bahraini  health  services.  The  natural  progression
of the  disease  among  those  patients,  in  particular
the prevalence  of  infection,  has  not  been  studied
previously. This  study  explored  this  part  of  the  dis-
ease to  raise  more  awareness  of  its  signiﬁcance  on
morbidity  and  mortality.
Most  studies  on  this  medical  topic  involved
children. A  study  performed  at  the  University  of
California  about  the  predictors  of  bacteremia  in
SCD children  found  that  white  cell  count,  abso-
lute neutrophil  count  and  level  of  bandemia  were
all independently  associated  with  bacteremia  [2].
Another study  in  Jamaica  conducted  from  1993  to
1996 investigated  the  cause  and  outcome  of  fever
in Jamaicans  with  homozygous  SCD.  The  study  con-
cluded that  acute  chest  syndrome  and  painful  crises
were the  most  important  complications  associated
with fever  in  SCD  patients  [3].As mentioned  above,  little  research  has  been
done on  adults  with  SCD.  Therefore,  we  aimed  to
explore the  cause  and  development  of  fever  in  adult
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atients  with  homozygous  SCD  during  their  hospi-
al stay.  We  also  examined  the  outcome  of  those
atients  and  the  prevalence  of  different  bacte-
ial infections/hospital  acquired  infections  in  SCD
atients. This  help  reveal  the  prevalence  of  infec-
ions in  this  population  and  whether  any  infection
revention methods  can  be  implemented  on  clinical
rounds.
ethods
his  was  a  retrospective  study  conducted  at  the
almaniya  Medical  Complex,  the  main  secondary
are and  teaching  hospital  in  the  Kingdom  of
ahrain.  The  rate  of  sickle  cell  disease  patients
n that  hospital  on  a  daily  basis  is  approximately
0%. At  the  same  time,  20—30%  of  the  accident  and
mergency  visits  at  that  hospital  are  for  sickle  cell
isease patients.
Data were  collected  retrospectively  from  all  of
he medical  records  of  patients  who  were  admitted
o the  medical  department  with  a diagnosis  ICD  10
f sickle  cell  disease  from  June,  2012  to  December,
012.
The medical  records  of  the  SCD  in-patients  that
ad a fever  at  their  time  of  admission  or  developed
 fever  during  their  hospitalization  were  evaluated.
hen, all  cases  that  developed  a healthcare-
ssociated  infection  (HAI)  is a localized  or  systemic
ondition  resulting  from  an  adverse  reaction  to  the
resence of  an infectious  agent(s)  or  its  toxin(s)
hat was  not  present  on  admission  to  the  acute  care
acility.
The information  for  the  study  forms  was  col-
ected from  the  medical  record  ﬁles  by  medical
esidents who  were  involved  in  the  care  of
hese patients.  The  information  collected  included:
emographic  data,  the  chief  complaint  of  the
atient  at  admission,  admission  diagnosis,  onset
nd duration  of fever,  clinical  symptoms  and  signs,
ype of  antimicrobials  used  and  the  duration  of
heir use,  laboratory  blood  investigation  on  admis-
ion and  follow  up,  hospital  stay  events,  whether
ubspecialty consultation  was  necessary,  radiology
nvestigations  performed  and  the  impression  at  dis-
harge. The  data  were  reviewed  and  analyzed  by
n infectious  disease  specialist.
esultshere  were  a total  of  565  admissions  during  the
eriod of  June,  2012  to  December,  2012.  Most
f these  patients  had  been  repeatedly  admitted
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Figure  1  Distribution  of  the  positive  cultures  among  dif-
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of vaso-occlusive  crises,  except  one  who  was  admit-erent  samples.
or  various  reasons;  thus,  there  were  actually
7 patients.  The  number  of  recurrent  admission
anged from  2  to  24  times  per  patient.  A  total  of
9 patients  had  a  fever  at  some  point  during  their
ospital stay,  and  33  of  the  patients  with  fever
ad positive  cultures  (55.93%).  The  cultures  were
one only  for  patients  who  were  admitted  with
ever or  developed  it  during  their  stay  at  the  hospi-
al. Unfortunately,  only  the  medical  records  of  17
atients were  found  and  included  in  the  ﬁnal  data
nalysis.
A blood  culture  was  performed  on  ﬁfteen  of  the
eventeen patients.  Of  those  15  patients,  seven  had
ositive cultures  (46.67%).  Staphylococcus  aureus
as isolated  from  ﬁve  of  the  positive  cultures
71.42%). One  methicillin-resistant  Staphylococcus
pidermidis (MRSE)  and  Candida  isolate  were  found
Fig.  1).
Urine cultures  were  performed  on  13  of  the  17
atients. Five  cultures  were  positive  (29.41%),  and
ach grew  a  different  organism:  extended  spectrum
-lactamase, Candida,  Escherichia  coli,  Acineto-
acter and  one  Enterococcus.  Four  patients  did  not
ave a  urine  culture  (23.53%),  and  eight  patients
ad sterile  urine  cultures  (47.06%).
Deep tracheal  aspiration  was  performed  on  ﬁve
atients  (29.41%).  The  samples  were  sterile  for  two
atients  and  positive  for  three  patients.  Two  of  the
ositive samples  had  multiple  organisms.  One  sam-
le had  S.  aureus,  Acinetobacter  MDR  and  Candida.
he other  sample  had  a  combination  of  Candida
nd Klebsiella. The  third  positive  sample  only  had
itrobacter.
A throat  swab  was  performed  on  three  patients.
ne sample  was  positive  for  Candida,  one  was  pos-
tive for  B-hemolytic  streptococcus  and  the  third
as sterile.
Of the  organisms  grown  in  the  different  cultures,
2.86% were  gram-positive,  mostly  S.  epidermidis,
t
tigure  2  Distribution  of  the  different  types  of  microor-
anisms.
3.33%  were  gram-negative  and  23.81%  were  Can-
ida (Fig.  2)
At  admission,  only  one  patient  had  a fever.  The
ajority developed  the  fever  after  being  in  the  hos-
ital for  72  h  (76.5%).  The  fever  duration  ranged
rom 1 to  24  days  with  an  average  of  7.23  days.  Clin-
cally, 88.24%  of  patients  experienced  body  pain,
ither generalized  or  localized  to  a body  limb  (sin-
le/multiple),  as  their  chief  compliant.  Five  of
he patients  had  chest  pain  in  addition  to  their
ther complaints  (29.41%).  Two  patients  had  pos-
tive chest  ﬁndings  on  examination,  described  as
ibasal chest  crepitations  in  one  and  wheezes  plus
ow oxygen  saturation  in  the  other.  The  white  cell
ount was  high  in  12  of  the  17  patients  and  ranged
rom 3.2  to  22.2  in  all  patients.
Nine of  the  17  patients  were  given  antibiotics
t admission.  Most  of  them  received  ceftriaxone
88.89%) and  one  received  a combination  of  eryth-
omycin  and  tazocin  (piperacillin  +  tazobactam).
uring the  hospital  stay  and  as  the  fever  devel-
ped, antibiotics  were  added  to  the  treatment
f all  but  two  patients  who  did  not  receive
ny antibiotics  during  their  stay.  Most  patients
ere on  multiple  antibiotics  at  the  same  time
52.94%), and  35.29%  of  patients  were  on  a single
ntimicrobial.  Ceftriaxone  was  used  most  com-
only as  a single  agent  or  in  combination  with
ancomycin, piperacillin/tazobactam  (tazocin)  and
rythromycin.  Some  of  the  patients  received  oral
ntibiotics,  such  as  ciproﬂoxacin,  cefuroxime  and
moxicillin/clavulanate.  Other  medications  were
sed in  various  combination  and  doses  included
eropenem/imepenem,  linezolid,  colisitin,  ﬂu-
onazole  and  tegacycline  (Fig.  3).
All patients  were  admitted  with  the  impressioned to  rule  out  a  pulmonary  embolism.  In  addition,
hey all  experienced  a  full  recovery  and  were
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tFigure  3  Antibiotics  used  during  hospital  stay  alone  or
in  combination.
discharged  to  return  home.  No  complications  were
encountered,  except  in  one  patient  who  was
admitted to  the  intensive  care  unit  but  was  even-
tually discharged  to  return  home.  At  discharge,
70.59% of  patients  had  been  diagnosed  with  vaso-
occlusive  crises:  two  with  acute  chest  syndrome,
two with  a  urinary  tract  infection,  one  with
acute cholecystitis,  one  with  upper  respiratory
tract infection  and  one  with  hemolytic  crises  in
combination.
Radiological  investigations  were  performed.  A
chest X-ray  was  performed  on  88.23%  of  the
patients and  was  normal  in  60%  of  the  patients.
One X-ray  showed  a  lower  lobe  inﬁltration,  and
that patient  was  diagnosed  with  pneumonia.  Three
of the  patients  had  increased  bronchial  markings,
one had  a  pleural  effusion  and  another  had  car-
diomegaly.  An  abdominal  ultrasound  was  performed
on six  patients;  a  CT  angiogram  was  performed  on
two patients;  one  patient  underwent  a  CT  brain
scan; one  patient  underwent  a  bone  scan;  and  one
patient underwent  an  echocardiogram.
The average  hospital  stay  ranged  from  5  to  37
days with  an  average  of  12.6  days,  which  is longer
than the  average  stay  for  other  medical  admissions.
Discussion
This  study  showed  that  SCD  patients  are  recurrently
admitted to  hospitals  at  a  signiﬁcant  rate,  which
puts them  at  a  high  risk  of  developing  a  hospital
acquired infection.  This  ﬁnding  is  not  unique  to
our hospital.  A  study  conducted  in  Atlanta,  USA
published  in  2010  about  the  frequency  of  acci-
dent and  emergency  visits  by  SCD  patients  had
a similar  ﬁnding.  They  found  that  on  average,
approximately  197,333  of  emergency  department
visits each  year  from  1999  and  2007  were  SCD
patients. Approximately  29%  of  those  visits  resulted
(
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n  hospital  admission  [4]. In  our  institution,  the
umber  of  accident  and  emergency  visits  for  SCD
atients  was  also  high  as  was  the  rate  of  admis-
ion.
In our  study,  we  found  that  that  many  SCD
atients developed  fever  as  an  inpatient;  thus,  we
nalyzed these  cases  to  evaluate  the  possibility
f developing  hospital  acquired  infections  in  this
opulation.  At  admission  only  one  patient  had  a
ever, and  during  the  hospital  stay  the  majority  of
atients, 13/17  (76.5%),  developed  fever  72  h after
dmission.  The  fever  duration  ranged  from  1  to  24
ays with  an  average  of  7.23  days.  We  also  found  a
igh rate  of  utilization  of  different  diagnostic  pro-
edures.
A descriptive  study  was  conducted  at  the  Boston
niversity School  of  Medicine  regarding  nosoco-
ial infections  in  a SCD  population.  It  described
ight serious,  nosocomially  transmitted  infections
n four  adult  patients  hospitalized  for  complica-
ions of  sickle  cell  disease,  which  led  to  death  in
ne patient  and  prolonged  hospital  stays  in  the
ther three  patients.  The  researchers  concluded
hat the  risk  of  infection  in  SCD  patients  can  be
educed  if  health  care  workers  are  especially  vigi-
ant in  adhering  to  hand  washing  and  other  infection
ontrol  measures  when  caring  for  these  patients.
dditionally, it  was  recommended  that  a patient
ith sickle  cell  disease  not  share  a  room  with  a
atient  known  to  have  or be  suspected  of  having  a
osocomial  or  community-acquired  infectious  dis-
ase [5].
Comparing  these  data  to  ours,  we  noticed  that
he majority  of  patients  had  a  positive  blood  cul-
ure that  indicated  contamination  with  methicillin
esistant S.  epidermidis. Only  two  cases  had  docu-
ented  blood  stream  infections  (0.03%).  One  case
as given  extended  spectrum  beta  lactamases  and
nother had  a Candida  infection.  Our  rate  of  infec-
ion was  much  lower  than  that  of  the  Boston
niversity School  of  Medicine  study.  A  retrospective
hart review  of  692  pediatric  ED  visits  of  children
ith SCD  during  a two-year  period  was  conducted
o determine  the  incidence  of  bacteremia  in  chil-
ren with  SCD  presenting  with  or  without  fever  to
 pediatric  ED  in  Vancouver,  Canada.  Seven  blood
ultures  had  bacterial  growth  (1.3%;  95%  conﬁdence
nterval, 0.5—2.1),  three  of  which  were  from  febrile
hildren  (1.7%;  95%  conﬁdence  interval,  0—3.6).  All
dentiﬁed microorganisms  were  part  of  the  normal
kin or  oral  ﬂora  and  could  represent  contamina-
ion, which  is  similar  to  the  ﬁndings  of  our  study
the most  commonly  identiﬁed  isolate  in  positive
lood  cultures  was  methicillin  resistant  S.  epider-
idis  (MRSE)).  None  of  the  patients  were  positive
or Streptococcus  pneumoniae. Thus,  there  was  a
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ery  low  rate  of  bacterial  growth  [6], which  also
grees  with  our  study  results.
Another  study  was  performed  in  Pennsylvania,
SA to  estimate  the  frequency  of  blood  stream
nfection (BSI)  among  admitted  SCD  patients.  The
harts of  adults  with  SCD  and  BSI  who  were  admit-
ed between  April,  1999  and  August,  2003  were
eviewed. During  this  period,  a  total  of  1692  hos-
ital admissions  for  193  adults  with  SCD  were
dentiﬁed, and  28%  of  those  patients  had  at  least
ne occurrence  of  a  positive  blood  culture,  with
9 occurrences  (17%)  considered  to  be  true  BSI.
osocomial BSI  occurred  in  34  episodes  (49%).  S.
neumoniae  was  rarely  encountered.  A  high  inci-
ence of  staphylococcal  BSI  in  adults  with  SCD  was
oted [7].  The  ﬁndings  of  the  Pennsylvania  study
greed  with  those  of  our  study:  no  cultures  were
ositive for  the  bacterial  infections  that  are  most
ommonly  expected  to  occur  in  SCD  patients.  This
ncludes  encapsulated  organisms,  such  as  Strepto-
occus  pneumoniae  and  Haemophilus  inﬂuenzae,
hich can  both  cause  pneumonia,  blood  infections,
nd meningitis.  Such  infections  pose  a  grave  threat
o infants  and  very  young  children  with  sickle  cell
isease.
A study  in  France  concerning  BSI  had  similar
ndings. Through  a  ﬁve-year  retrospective  anal-
sis of  a  cohort  of  900  patients  followed  at  the
ervice de  Médecine  Interne  I,  Hôpital  Henri  Mon-
or, Créteil,  France,  56  episodes  of  BSI  were  found
n 47  patients.  The  incidence  rate  of  BSI  was  1.2
pisodes  per  100  patient-years.  For  the  patients
n this  cohort,  those  with  BSI  were  more  likely
o be  younger  (p  =  0.001),  to  have  Hb-S  disease
p =  0.008),  severe  disease  (p  =  0.001),  or  additional
mmunosuppression  (p  = 0.05).  BSI  was  hospital-
cquired in  46%  of  the  cases  and  was  usually
ssociated with  venous  catheters  (41%)  and  was
aused by  S.  aureus  (34%).  Pneumococci  were  rarely
dentiﬁed  (10.7%).  Despite  an  adequate  duration  of
ntibiotic therapy,  the  course  of  BSI  was  marked
y a high  frequency  of  associated  bone-joint  infec-
ion. Factors  associated  with  the  occurrence  of
one-joint  infection  were  previous  osteonecro-
is (relative  risk,  2.5;  95%  conﬁdence  interval,
.2—5.3) and  S.  aureus  infection  (relative  risk,  3.8;
5% conﬁdence  interval,  1.8—8.4).  The  researchers
lso concluded  that  BSI  is  a  much  rarer  event  in
dults with  SCD  compared  to  children.  It  mainly
ccurs in  those  with  a  severe  underlying  disease  and
 venous  catheter.  These  patients  have  a  high  risk  of
ssociated  bone-joint  infection  and  therefore  must
e closely  monitored  [8].
In our  study,  29%  (5/17)  of  patients  had  a
ositive urine  culture  as  part  of  their  fever  work-
p. Only  two  patients  had  a  clear  diagnosis  of
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ospital  acquired  UTI.  Therefore,  the  remaining
ositive cultures  may  be  the  result  of  asymptomatic
acteriuria (ASB).  A  cross  sectional  study  regarding
CD  and  ASB  was  performed  in  Jamaica.  The  study
howed  that  of  the  266  urine  samples  collected,  234
ere sterile  and  29  had  signiﬁcant  bacteriuria  yield-
ng a prevalence  of  probable  ASB  in  10.9%  (29/266)
f the  patients  sampled.  Fourteen  patients  had
onﬁrmed  ASB  (prevalence  5.3%)  of  which  13  had
yuria. Females  were  14.7  times  more  likely  to
ave conﬁrmed  ASB  than  males  (95%  CI  1.8—121.0).
he number  of  recorded  visits  for  symptomatic  UTI
as increased  by  a factor  of  2.5  (95%  CI  1.4—4.5,
 <  0.005)  in  the  conﬁrmed  ASB  group.  There  was  no
ssociation  of  ASB  with  a  history  of  gram-negative
epsis. ASB  is  a signiﬁcant  problem  in  individuals
ith SCD  [9].
Another  study  conducted  in  Nigeria,  which  has  a
igh prevalence  of  SCD,  investigated  the  incidence
f UTI.  Bacteriuria  was  found  in  65  children  with
CD (26%)  and  514  controls  (20.4%),  p >  0.05.  E.  coli
16 (27.7%)]  and  Klebsiella  species  [16(24.6%)]
ere the  predominant  isolates  in  the  SCD  group.
igniﬁcant bacteriuria  occurred  in  patients  with
ther clinical  conditions,  such  as  pneumonia  and
epticemia.  Urinary  tract  infection  is  common  in
hildren with  SCD.  Routine  screening  is  therefore
ecommended during  fever  [10]. These  ﬁndings
re comparable  to  our  study  in  which  the  most
ommon organisms  isolated  were  gram-negative
acteria.
In our  study,  the  rate  of  hospital  acquired  pneu-
onia was  higher  than  the  other  types  of  hospital
cquired infections.  The  rate  of positive  sputum
ulture in  this  study  for  all  of  the  patients  with
uspicion of  pneumonia  was  4/17  (23.5%).  One
f the  cases  of  pneumonia  was  associated  with
cute chest  syndrome.  In  our  study,  the  prevalence
f hospital  acquired  pneumonia  nearly  equaled
.05%.
In our  study,  we  found  that  most  of  the  cases
f fever  in  SCD  patients  are  of  a noninfectious
tiology.  Most  fevers  were  intensively  investigated
ithout determination  of  an  infectious  cause.
There was  a high  rate  of  inappropriate  antibi-
tic use  among  these  patients.  The  patients  were
iven different  combinations  of  multiple  antibi-
tics,  which  were  not  based  on  a positive  culture
r correlated  with  the  patient’s  clinical  presenta-
ion. This  improper  practice  can  lead  to  serious
ntibiotic resistance  in  the  SCD  population,  espe-
ially because  they  are  known  to  be  frequently
dmitted for  a  variety  of  conditions  that  are  fre-
uently treated  with  antibiotics.  This  can  lead
o the  occurrence  of  infection  in  this  popula-
ion with  multi-resistant  organisms,  which  may
CN
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require  the  administration  of  more  expensive  and
broader spectrum  antibiotics.  This  will  impact  the
cost of  treatment  and  the  ﬁnancial  burden  of
patients.
In conclusion,  there  is a  low  rate  of  hospital
acquired infection  among  SCD  patients.  Special
attention to  the  infection  control  measures  in
SCD patients  is  needed,  and  SCD  patients  need
to be  considered  as  a  special  high  risk  group.
Most of  the  cases  reviewed  here  developed  a
fever  with  no  clear  cause  even  after  exten-
sive diagnostic  evaluation;  thus,  those  fevers  may
have been  of  a  non-infectious  etiology  in  this
population. There  was  a  high  rate  of  contami-
nation or  colonization  among  the  cultures  that
were  collected,  which  also  emphasizes  the  impor-
tance  of  proper  sample  collection.  Fortunately,
none of  the  patients  had  any  of  the  common
preventable  infections  as  a  result  of  the  high  vac-
cination  coverage  and  strong  vaccination  program
in place  in  the  Kingdom  of  Bahrain.  There  is  a
high rate  of  inappropriate  use  of  antibiotics  by
clinicians  in  Bahrain,  which  must  be  addressed
though a  proper  antibiotic  stewardship  program.
SCD patients  are  at  a  high  risk  of  different  bacte-
rial infections.  The  common  infectious  organisms
are S.  pneumoniae  and  H.  inﬂuenzae, and  these
are preventable  by  establishing  a  good  vaccination
program.
This study  has  some  limitations,  including  the
small  number  of  patients  and  the  retrospective
nature of  the  study,  which  resulted  in  some  miss-
ing information  and  a  substantial  decrease  in  the
number  of  patients.  Further  studies  have  to  empha-
size the  importance  of  HAI  in  SCD  patients  and  their
impact  on  morbidity  and  mortality.Funding
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